Khrom Capital Management LLC
$1.1B in tracked AUM across 14 positions as of Q1 2026.
Khrom Capital Management's Q1 2026 filing captures a $1.09B, 14-position fund executing one of the more balanced sector rotations in this cohort — simultaneously adding financial services (Capital One +$150M, Synchrony trimmed), healthcare (Soleno +$50.6M, Universal Health reduced, Acadia trimmed), logistics (GXO +$39.1M, +63% shares), technology (DoorDash +$101.9M, Stride +$42.9M, +109% shares), and industrials (Medline +$31.3M, Reinsurance Group +$59.6M) while eliminating seven names that had served as the portfolio's 2024-2025 anchors (Tenet Healthcare, Credit Accept, United Airlines, Signet Jewelers, LGI Homes, and two Amcor/HCI share-class switches). The fund's 21 total changes — 7 new, 7 sold, 4 increased, 3 decreased — is unusually high turnover for a 14-name book, which points to a desk that treats each quarter as a portfolio-construction exercise rather than a buy-and-hold vehicle. Capital One ($149.6M, 13.7% of AUM) opened as the new largest holding, replacing Amcor's 15.4% weight from Q4 2025; DoorDash ($101.9M, 9.3%) and TD SYNNEX ($101.8M, 9.3%) are similarly sized opens that diversify the technology exposure away from the software-and-semiconductor complex. GXO (+63% shares, +$39.1M) and Stride (+109% shares, +$42.9M) are the largest increases — names in logistics and online education that benefit from reshoring and demographic-tailwinds respectively. The sells cluster in two themes: consumer-credit exposure (Credit Accept -$61.3M, United Airlines -$46.8M, Signet Jewelers -$32.1M, LGI Homes -$14.7M) and healthcare positioning that the manager appears to be rotating within the sector (Tenet Healthcare -$100.2M, Universal Health -$20.1M) while adding Soleno Therapeutics in rare disease. At a 79.00 whaleScore, this is a concentrated, high-turnover book whose Q1 activity is more informative than its static snapshot: the manager is actively rebalancing sector weights around a base-case view that favors financial services, logistics, education technology, and select biotech over consumer credit, traditional healthcare operators, and travel.
Quarter at a glance — Q1 2026
Position-change comparison pending.
Top 10 holdings
By portfolio weight as of Q1 2026.